Cybin Inc. Common Stock (HELP)

Cybin Inc. Common Stock (HELP) is listed on Nasdaq, where it has traded since November 10, 2020.

Listed On
Nasdaq
Listed Since
November 10, 2020
Employees
50
Market Cap
$921M

About Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 100 institutions reported holding HELP, with 29.9 million shares worth $197.6 million in aggregate. The largest reported holder was VR Adviser, with 3.9 million shares worth $25.5 million. Of the 5 largest holders listed below, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter.

InstitutionSharesValueQuarter change
VR Adviser3,851,654$25MUnchanged
Orbimed Advisors3,271,400$22MReduced 14.65%
Adage Capital Partners GP,3,060,000$20MAdded 337.14%
Millennium Management2,632,156$17MAdded 8.95%
Rosalind Advisors1,956,814$13MAdded 27.74%

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is HELP?

Cybin Inc. Common Stock (HELP) is listed on Nasdaq, where it has traded since November 10, 2020.

Who are the largest institutional holders of HELP?

In 13F filings for the quarter ended June 30, 2026, the largest reported holders of HELP were VR Adviser, Orbimed Advisors and Adage Capital Partners GP,.

How many institutions own HELP?

100 institutions reported a position in HELP for the quarter ended June 30, 2026, worth $197.6 million in total.

Did institutions buy or sell HELP last quarter?

Of the 5 largest reported holders, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for HELP.

Every reported institutional holder, plus insider and congressional trades in HELP, on SentiSense.